MDCM.L
Latest Trade
397.90GBpChange
0.60(+0.15%)Volume
1,555,989Today's Range
-
408.1052 Week Range
-
410.30As of on the London Stock Exchange (LON) ∙ Minimum 15 minute delay
Previous Close | 397.30 |
|---|---|
Open | 408.10 |
Volume | 1,555,989 |
3M AVG Volume | 18.60 |
Today's High | 408.10 |
Today's Low | 395.60 |
52 Week High | 410.30 |
52 Week Low | 288.30 |
Shares Out (MIL) | 737.24 |
Market Cap (MIL) | 2,946.76 |
Forward P/E | 15.20 |
Dividend (Yield %) | -- |
Mediclinic International Reiterates FY Guidance
Mediclinic International Says Hirslanden Delivered HY Growth Of Around 5.0% In Revenue
Mediclinic International Says Trading In Line With Expectations For H1
Mediclinic International plc (Mediclinic) is an international private healthcare services provider. Mediclinic is focused on providing acute-care, specialist-orientated, multi-disciplinary healthcare services. Mediclinic’s operational divisions includes Hirslanden Switzerland, Mediclinic Southern Africa and Mediclinic Middle East. Mediclinic comprises of 77 hospitals, five sub-acute hospitals, 12 day case clinics and 21 outpatient clinics. Hirslanden Switzerland operates 18 hospitals, two day case clinics and three outpatient clinics in Switzerland with over 1800 inpatient beds. Mediclinic Southern Africa operates 49 hospitals, five sub-acute hospitals and eight day case clinics across South Africa and three hospitals in Namibia with over 8500 inpatient beds. Mediclinic Middle East operates seven hospitals, two day case clinics and 18 outpatient clinics with over 900 inpatient beds in the United Arab Emirates.
Industry
Healthcare Facilities
Executive Leadership
Edwin Hertzog
Non-Executive Chairman of the Board
Ronnie van der Merwe
Chief Executive Officer, Executive Director
Jurgens Myburgh
Group Chief Financial Officer, Executive Director
David Hadley
Chief Executive Officer - Mediclinic Middle East
Daniel Liedtke
Chief Executive Officer: Hirslanden
Price To Earnings (TTM) | 23.39 |
|---|---|
Price To Sales (TTM) | 0.96 |
Price To Book (MRQ) | 0.88 |
Price To Cash Flow (TTM) | 8.42 |
Total Debt To Equity (MRQ) | 81.42 |
LT Debt To Equity (MRQ) | 77.63 |
Return on Investment (TTM) | 2.41 |
Return on Equity (TTM) | 2.18 |
Mediclinic International Plc <MEIJ.J> <MDCM.L> reported a 4% rise in half-year core earnings on Thursday as the company's Swiss business adjusted to regulatory changes and its South African and Middle Eastern operations performed well.
Mediclinic International Plc reported a 4% rise in half-year core earnings on Thursday as the healthcare company's Swiss business adjusted to regulatory changes and its South African and Middle Eastern operations performed well.
Mediclinic International Plc said on Wednesday it expects higher first-half core earnings, as the healthcare company's Swiss business adjusted to regulatory changes and its Southern Africa and Middle East operations performed well.
Mediclinic International Plc <MDCM.L> <MEIJ.J> said on Wednesday it expects an increase in first-half core earnings, as the healthcare company's Swiss business adjusted to regulatory changes and its South Africa and Middle East operations performed well.
Mediclinic International Plc, reported a 4% fall in full-year core profit on Thursday, in line with market expectations, hit by regulatory changes for its Swiss business.
* MEDICLINIC INTERNATIONAL PLC - GROUP ADJUSTED FULL-YEAR FINANCIAL RESULTS IN LINE WITH MARKET EXPECTATIONS
Mediclinic International Plc, reported a 4% fall in full-year core profit on Thursday, in line with market expectations, reflecting the impact of regulatory changes on its Swiss business.
Mediclinic International Plc said it expects full-year group core profit to fall by 3.5 percent, in line with market expectations in a challenging healthcare environment.
* GROUP RESULTS FOR 2019 FINANCIAL YEAR WERE IN LINE WITH MARKET EXPECTATIONS
Mediclinic International Plc plans to reduce capex for its Swiss business, open more outpatient surgery units and medical centres in order to mitigate regulatory challenges in Switzerland's healthcare market.
Mediclinic International Plc reported a 8 percent decline in half-year core profit on Thursday reflecting a smaller contribution from Hirslanden, its Swiss operation.
* MEDICLINIC INTERNATIONAL - IN MIDDLE EAST, 182-BED MEDICLINIC PARKVIEW HOSPITAL IN DUBAI OPENED IN SEPTEMBER ON TIME AND IN BUDGET
* MEDICLINIC INTNL PLC - COMBINATION - HIRSLANDEN LA COLLINE AND GRANGETTES
Mediclinic <MDCM.L> took a hefty $863 million (646.28 million pounds) writedown on its Swiss business on Thursday, tipping South Africa's biggest private hospital group into an annual loss and sending its shares tumbling.
South African private hospital group Mediclinic reported a 3 percent rise in annual core profit on Thursday, boosted by a recovery in its Middle Eastern operations.
* SAYS GROUP EXPECTS TO DELIVER ADJUSTED FINANCIAL RESULTS FOR YEAR MARGINALLY AHEAD OF EXPECTATIONS
* MEDICLINIC INTERNATIONAL PLC - RONNIE VAN DER MERWE (CHIEF CLINICAL OFFICER AND CHIEF EXECUTIVE OFFICER) WILL SUCCEED DANIE MEINTJES AS CEO OF COMPANY
* ANNOUNCES APPOINTMENT OF CAREL ARON VAN DER MERWE, CURRENTLY GROUP CHIEF CLINICAL OFFICER, AS CHIEF EXECUTIVE OFFICER DESIGNATE
Expectations that Mediclinic International Plc <MDCM.L> <MEIJ.J> would succeed in taking over Britain's Spire Healthcare Group <SPI.L> fell on Thursday after South Africa's largest private hospital group said no deal had been reached.
* ALTHOUGH DISCUSSIONS HAVE CONTINUED, NO AGREEMENT HAS YET BEEN REACHED ON ANY OF KEY TERMS OF AN OFFER Source text for Eikon: Further company coverage:
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.